In this episode, experts discuss the latest advancements in the multimodal treatment of undifferentiated pleomorphic sarcoma of the extremities.
Moving the Needle in Undifferentiated Pleomorphic Sarcoma
In this episode, experts discuss the rationale behind the combined treatment in the Stand Up to Cancer SARC 032 trial.
In this episode, experts discuss the potential of radiation therapy to enhance immune response in soft tissue sarcomas.
In this episode, experts shed light on the surgical approach to soft tissue sarcomas.
In this episode, experts discuss the impact of neoadjuvant radiation and immunotherapy on surgical planning in patients with soft tissue sarcomas.
In this episode, experts discuss the landmark SARC 032 study, highlighting the importance of multidisciplinary collaboration.
In this episode, experts highlight the key takeaways from the Stand Up to Cancer SARC 032 study and its clinical implications.
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
4
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma
5